Publication Results (47)

• «
• 1
• 2
• »

• Timeliness and modality of treatment for new cancer diagnoses during the COVID-19 pandemic in Canada

  Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Dare A, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Look Hong NJ, Witterick IJ, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Tinmouth J, Eskander A. JAMA Netw Open. 2023; 6(1):e2250394. Epub 2023 Jan 10. DOI: https://doi.org/10.1001/jamanetworkopen.2022.50394

• Effect of chronic comorbidities on follow-up colonoscopy after positive colorectal cancer screening results: a population-based cohort study

  Bhatia D, Sutradhar R, Paszat LF, Rabeneck L, Singh S, Tinmouth J, Lipscombe LL. Am J Gastroenterol. 2022; 117(7):1137-45. Epub 2022 Mar 22. DOI: https://doi.org/10.14309/ajg.0000000000001742

• A pragmatic randomized controlled trial of an endoscopist audit and feedback report for colonoscopy

  Tinmouth J, Sutradhar R, Li Q, Patel J, Baxter NN, Llovet D, Paszat LF, Rabeneck L. Am J Gastroenterol. 2021; 116(10):2042-51. Epub 2021 Sep 13. DOI: https://doi.org/10.14309/ajg.0000000000001498

• Uptake and short-term outcomes of high-risk screening colonoscopy billing codes: a population-based study among young adults

  Paszat L, Sutradhar R, Luo J, Tinmouth J, Rabeneck L, Baxter NN. J Can Assoc Gastroenterol. 2022; 5(2):86-95. Epub 2021 Jun 10. DOI: https://doi.org/10.1093/jcag/gwab014

• Perforation and post-polypectomy bleeding complicating colonoscopy in a population-based screening program

  Paszat LF, Sutradhar R, Luo J, Rabeneck L, Tinmouth J. Endosc Int Open. 2021; 9(4):E637-45. Epub 2021 Apr 15. DOI: https://doi.org/10.1055/a-1381-7149

• Influence of chronic comorbidities on periodic colorectal cancer screening participation: a population-based cohort study

  Bhatia D, Sutradhar R, Tinmouth J, Singh S, Lau C, Lipscombe LL. Prev Med. 2021; 147:106530. Epub 2021 Mar 24. DOI: https://doi.org/10.1016/j.ypmed.2021.106530

• Overall health care cost during the year following diagnosis of colorectal cancer stratified by history of colorectal evaluative procedures

  Paszat L, Sutradhar R, Luo J, Rabeneck L, Tinmouth J, Baxter NN. J Can Assoc Gastroenterol. 2021; 4(6):274–83. Epub 2021 Mar 6. DOI: https://doi.org/10.1093/jcag/gwab001

• Decreased colorectal cancer incidence and incidence-based mortality in the screening-age population of Ontario

  Paszat LF, Sutradhar R, Corn E, Tinmouth J, Baxter NN, Rabeneck L. J Can Assoc Gastroenterol. 2021; 4(3):146–55. Epub 2020 Oct 15. DOI: https://doi.org/10.1093/jcag/gwaa035

• Morbidity and mortality following major large bowel resection for colorectal cancer detected by a population-based screening program

  Paszat LF, Sutradhar R, Corn E, Luo J, Baxter NN, Tinmouth J, Rabeneck L. J Med Screen. 2021; 28(3):252-60. Epub 2020 Sep 20. DOI: https://doi.org/10.1177/0969141320957361

• Uptake of colorectal cancer screening by physicians is associated with greater uptake by their patients

  Litwin O, Sontrop JM, McArthur E, Tinmouth J, Rabeneck L, Vinden C, Sood MM, Baxter NN, Tanuseputro, Welk B, Garg AX. Gastroenterology. 2020; 158(4):905-14. Epub 2019 Nov 1. DOI: https://doi.org/10.1053/j.gastro.2019.10.027

• Screening for a new primary cancer in patients with existing metastatic cancer: a retrospective cohort study

  Cheung MC, Tinmouth J, Austin PC, Fischer HD, Fung K, Singh S. CMAJ Open. 2018; 6(4):E538-E43. Epub 2018 Nov 5. DOI: 10.9778/cmajo.20180045.

• Validation of 5 key colonoscopy-related data elements from Ontario health administrative databases compared to the clinical record: a cross-sectional study

  Tinmouth J, Sutradhar R, Liu N, Baxter NN, Paszat L, Rabeneck L. CMAJ Open. 2018; 6(3):E330-8. Epub 2018 Aug 13.

• Predictors of non-adherence to colorectal cancer screening among immigrants to Ontario, Canada: a population-based study

  Shen SC, Lofters A, Tinmouth J, Paszat L, Rabeneck L, Glazier RH. Prev Med. 2018; 111:180-9. Epub 2018 Mar 13.

• Temporal trends in postcolonoscopy colorectal cancer rates in 50- to 74-year-old persons: a population-based study

  Murthy SK, Benchimol EI, Tinmouth J, James PD, Ducharme R, Rostom A, Dubé C. Gastrointest Endosc. 2018; 87(5):1324-34.e4. Epub 2018 Jan 6.

• BETTER HEALTH: Durham -- protocol for a cluster randomized trial of BETTER in community and public health settings

  Paszat L, Sutradhar R, O'Brien MA, Lofters A, Pinto A, Selby P, Baxter N, Donnelly PD, Elliott R, Glazier RH, Kyle R, Manca D, Pietrusiak MA, Rabeneck L, Sopcak N, Tinmouth J, Wall B, Grunfeld E. BMC Public Health. 2017; 17:754. Epub 2017 Sep 29.

• Risk of colorectal cancer after a negative colonoscopy in low-to-moderate risk individuals: impact of a 10-year colonoscopy

  Murthy SK, Dubé C, Rostom A, Benchimol EI, Ducharme R, Sutradhar R, Rabeneck L, Paszat L, Tinmouth J. Endoscopy. 2017; 49(12):1229-36. Epub 2017 Sep 15.

• Repeat colonoscopy within 6 months after initial outpatient colonoscopy in Ontario: a population-based cross-sectional study

  Paszat L, Sutradhar R, Baxter NN, Tinmouth J, Rabeneck L. Can J Gastroenterol Hepatol. 2017; 2017:5917057. Epub 2017 Sep 7.

• Repeated faecal occult blood testing is associated with decreased advanced colorectal cancer risk: a population-based study

  James PD, Rabeneck L, Yun L, Paszat L, Baxter NN, Govindarajan A, Antonova L, Tinmouth JM. J Med Screen. 2017; 25(3):141-8. Epub 2017 Sep 1.

• Anesthesia assistance in outpatient colonoscopy and risk of aspiration pneumonia, bowel perforation, and splenic injury

  Bielawska B, Hookey LC, Sutradhar R, Whitehead M, Xu J, Paszat LF, Rabeneck L, Tinmouth J. Gastroenterology. 2018; 254(1):77-85.e3. Epub 2017 Aug 30.

• Risk of colorectal cancer among immigrants to Ontario, Canada

  Paszat L, Sutradhar R, Liu Y, Baxter NN, Tinmouth J, Rabeneck L. BMC Gastroenterol. 2017; 17(1):85.

• Regional differences in use of endoscopic ultrasonography in Ontario: a population-based retrospective cohort study

  James PD, Hegagi M, Antonova L, Tinmouth J, Heitman SJ, Simone C, Yeung E, Yong E. CMAJ Open. 2017; 5(2):E437-43.

• Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening

  Goede SL, Rabeneck L, van Ballegooijen M, Zauber AG, Paszat LF, Hoch JS, Yong JH, Kroep S, Tinmouth J, Lansdorp-Vogelaar I. PLoS One. 2017; 12(3):e0172864. Epub 2017 Mar 15.

• Do primary care provider strategies improve patient participation in colorectal cancer screening?

  Baxter NN, Sutradhar R, Li Q, Daly C, Honein-AbouHaidar GN, Richardson DP, Del Giudice L, Tinmouth J, Paszat L, Rabeneck L. Am J Gastroenterol. 2017; 112(4):622-32. Epub 2017 Feb 28.

• A centrally generated primary care physician audit report does not improve colonoscopy uptake after a positive fecal occult blood test in Ontario’s ColonCancerCheck Program

  Stock D, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J. Curr Oncol. 2017; 24(1):47-51.

• The quality of colonoscopy reporting in usual practice: are endoscopists reporting key data elements?

  Hadlock SD, Liu N, Bernstein M, Gould M, Rabeneck L, Ruco A, Sutradhar R, Tinmouth JM. Can J Gastroenterol Hepatol. 2016; 2016:1929361.

• Interval colorectal cancers following guaiac fecal occult blood testing in the Ontario ColonCancerCheck program

  Paszat L, Sutradhar R, Tinmouth J, Baxter N, Rabeneck L. Can J Gastroenterol Hepatol. 2016; 2016:4768728. Epub 2016 May 8.

• Colonic stents for colorectal cancer are seldom used and mainly for palliation of obstruction: a population-based study

  Borowiec AM, Wang CSK, Yong E, Law C, Coburn N, Sutradhar R, Baxter N, Paszat L, Tinmouth J. Can J Gastroenterol Hepatol. 2016; 2016:1945172. Epub 2016 Mar 29.

• Small-area variation in screening for cancer, glucose and cholesterol in Ontario: a cross-sectional study

  Fernandes KA, Sutradhar R, Borkhoff CM, Baxter N, Lofters A, Rabeneck L, Tinmouth J, Paszat L, Ontario Cancer Screening Research Network. CMAJ Open. 2015; 3(4):E1-9.

• Repeat colonoscopy after a colonoscopy with a negative result in Ontario: a population-based cohort study

  Hol L, Sutradhar R, Gu S, Baxter NN, Rabeneck L, Tinmouth JM, Paszat LF, the investigators of the Ontario Cancer Screening Research Network. CMAJ Open. 2015; 3(2):E244-50.

• Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices

  Correia A, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J. Prev Med. 2015; 76:115-22. Epub 2015 Apr 17.

• Mailed participant reminders are associated with improved colonoscopy uptake after a positive FOBT result in Ontario’s ColonCancerCheck program

  Stock D, Rabeneck L, Baxter NN, Paszat LF, Sutradhar R, Yun L, Tinmouth J. Implement Sci. 2015; 10:35.

• Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders

  Tinmouth J, Patel J, Austin PC, Baxter NN, Brouwers MC, Earle C, Levitt C, Lu Y, Mackinnon M, Paszat L, Rabeneck L.Int J Cancer. 2015; 136(6):e697-703. Epub 2014 Sep 23.

• Evaluating the impact of public health initiatives on trends in fecal occult blood test participation in Ontario

  Honein-AbouHaidar GN, Rabeneck L, Paszat LF, Sutradhar R, Tinmouth J, Baxter NN. BMC Cancer. 2014; 14:537. Epub 2014 Jul 25.

• Sessile serrated polyps at screening colonoscopy: Have they been under diagnosed?

  Tinmouth J, Henry P, Hsieh E, Baxter NN, Hilsden RJ, McGregor SE, Paszat LF, Ruco A, Saskin R, Schell AJ, Torlakovic EE, Rabeneck L. Am J Gastroenterol. 2014; 109(11):1698-704. Epub 2014 Jul 8.

• Advanced proximal neoplasia of the colon in average-risk adults

  Rabeneck L, Paszat LF, Hilsden RJ, McGregor SE, Hsieh E, Tinmouth JM, Baxter NN, Saskin R, Ruco A, Stock D. Gastrointest Endosc. 2014; 80(4):660-7. Epub 2014 Mar 26.

• Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response

  Tinmouth J, Baxter NN, Paszat LF, Rabeneck L, Sutradhar R, Yun L. BMJ Open. 2014; 4(3):e004494. Epub 2014 Mar 12.

• Location, size, and distance: criteria for quality in esophagogastroduodenoscopy reporting for pre-operative gastric cancer evaluation

  Ravindran NC, Vasilevska-Ristovska J, Coburn NG, Mahar A, Zhang Y, Gunraj N, Sutradhar R, Law CH, Tinmouth J. Surg Endosc. 2014; 28(5):1660-7. Epub 2014 Jan 23.

• Disparities in receipt of screening tests for cancer, diabetes and high cholesterol in Ontario, Canada: a population-based study using area-based methods

  Borkhoff CM, Saskin R, Rabeneck L, Baxter NN, Liu Y, Tinmouth J, Paszat LF. Can J Public Health. 2013; 104(4):e284-90.

• Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis

  Murthy SK, Steinhart AH, Tinmouth J, Austin PC, Daneman N, Nguyen GC. Aliment Pharmacol Ther. 2012; 36(11-12):1032-9. Epub 2012 Oct 14.

• ColonCancerCheck primary care invitation pilot project: family physician perceptions

  Tinmouth J, Ritvo P, McGregor SE, Guglietti C, Green J, Claus D, Levitt C, Paszat LF, Rabeneck L. Can Fam Physician. 2012; 58(10):e570-7.

• «
• 1
• 2
• »